These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1576147)

  • 41. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts.
    Rose AG; Cooper DK; Human PA; Reichenspurner H; Reichart B
    J Heart Lung Transplant; 1991; 10(2):223-34. PubMed ID: 2031919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous immunoglobulin delays xenogeneic hyperacute rejection in a model of pig liver perfused with human blood.
    Gautreau C; Grosse H; Fabre M; Soubrane O; Woimant G; Lobontiu A; Kojima T; Cherruau B; Devillier P; Houssin D; Cardoso J
    Transplant Proc; 1996 Apr; 28(2):764. PubMed ID: 8623390
    [No Abstract]   [Full Text] [Related]  

  • 43. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
    Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
    Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
    Candinas D; Bach FH; Hancock WW
    Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
    [No Abstract]   [Full Text] [Related]  

  • 45. Can fetal xeno whole-organ (heart, lung, kidney, and liver) grafts escape from hyperacute rejection in experimental discordant combinations as compared with adult xenografts?
    Tsuji K; Kanai N; Kise Y; Takebe K; Shimura T; Hagihara M; Kitamura M; Hiraga S; Sato K; Takahashi T; Kakita A; Yoshida Y; Gojyo S; Kitamura S; Nakajima S; Kato H
    Transplant Proc; 1997 Nov; 29(7):3022-3. PubMed ID: 9365653
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular immune reaction in hyperacute rejection.
    Wada S; Ochikubo H; Sugawara Y; Sueda T; Fujii K; Kajihara H; Matsuura Y
    Transplant Proc; 1998 Nov; 30(7):3818-20. PubMed ID: 9838672
    [No Abstract]   [Full Text] [Related]  

  • 47. Transplantation of MCP cardiac xenografts into baboon recipients.
    Kadner A; Chen RH; Farivar RS; Santerre D; Adams DH
    Transplant Proc; 2001; 33(1-2):770-2. PubMed ID: 11267062
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiac xenotransplantation.
    Pham MX; Hunt SA; Johnson FL
    Coron Artery Dis; 2004 Mar; 15(2):99-105. PubMed ID: 15024297
    [No Abstract]   [Full Text] [Related]  

  • 49. The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts.
    Suckfüll MM; Pieske O; Müdsam M; Babic R; Hammer C
    Transplantation; 1994 Jan; 57(2):262-7. PubMed ID: 8310518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Xenogeneic organ transplantation].
    Shirakura R
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():659-64. PubMed ID: 15861725
    [No Abstract]   [Full Text] [Related]  

  • 51. Ethical aspects in xenotransplantation.
    Cortesini R
    Transplant Proc; 1998 Aug; 30(5):2463-4. PubMed ID: 9723538
    [No Abstract]   [Full Text] [Related]  

  • 52. Delay of xenogeneic hyperacute rejection by BN 52021 in a model of rabbit to pig liver transplantation.
    Boillot O; Patrzalek D; Cardoso J; Fontaliran F; Soubrane O; el Meteni M; Salame E; Houssin D
    Transplant Proc; 1996 Apr; 28(2):767. PubMed ID: 8623392
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperacute rejection models: ex vivo xenoperfusion systems.
    Grinyo JM; Cruzado JM; Torras J
    Transplant Proc; 1999; 31(1-2):970-1. PubMed ID: 10083432
    [No Abstract]   [Full Text] [Related]  

  • 54. Transplanting porcine hearts to humans.
    Bach FH
    BMJ; 1996 Mar; 312(7032):651-2. PubMed ID: 8597718
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccinia virus complement control protein inhibits hyperacute xenorejection.
    Anderson JB; Smith SA; Kotwal GJ
    Transplant Proc; 2002 Jun; 34(4):1083-5. PubMed ID: 12072283
    [No Abstract]   [Full Text] [Related]  

  • 56. Avoiding compliance with histocompatibility dogma using immune privileged cell xenografts.
    Haider HKh; Lei Y; Jiang S; Law PK; Sim EK
    Ann Thorac Surg; 2003 Jul; 76(1):339-40; author reply 340. PubMed ID: 12842584
    [No Abstract]   [Full Text] [Related]  

  • 57. Naive neutrophils and xenotransplantation.
    al-Mohanna FA; Collison KS; Allen SP; Stern D; Yacoub MH
    Lancet; 1996 Nov; 348(9036):1246. PubMed ID: 8898060
    [No Abstract]   [Full Text] [Related]  

  • 58. Hyperacute rejection: fact or fancy.
    Platt JL
    Transplantation; 2000 Mar; 69(6):1034-5. PubMed ID: 10762203
    [No Abstract]   [Full Text] [Related]  

  • 59. New frontiers: the 2002 FASEB Summer Research Conference in Transplant Immunology.
    Ingulli E
    Am J Transplant; 2003 Feb; 3(2):121-7. PubMed ID: 12603207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Xenotransplantation and social risks].
    Gubernatis G; Kliemt H
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1017-9. PubMed ID: 11004916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.